Friday 6 November 2026 Export CAI’s income statement to Excel — free account

Caris Life Sciences,�Inc.

Caris Life Sciences,�Inc.’s revenue for fiscal 2025 (year ended December 2025) was $812.0 million, up 97.0% from fiscal 2024.

Revenue: +27.0%
EPS: −40.3%
Free cash flow: −140.2%
Total debt: +4.46%

Quarter to September 2026, against a year earlier

Insider buying

25.11 0.92 −3.53%

Follow CAI

Alert me

Market cap: $7.4B
P/E: 73.9×
Fwd P/E: 254×
Dividend yield: —
F-score: n/a
Altman Z: 3.55
Beneish M: −2.71
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Caris Life Sciences,�Inc. (CAI) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Caris Life Sciences,�Inc. (CAI) trades at a P/E ratio of 73.9×. Over the past ten years it has ranged from 0.0× (June 2026) to 106× (October 2026); the current reading is higher than 89% of that period. That is above the Biotechnology industry median of 10.6× and above the Healthcare sector median of 24.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CAI/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Caris Life Sciences,�Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CAI/metrics/pe-ratio">Caris Life Sciences,�Inc. (CAI) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—

Period	P/E ratio	Change
Sep 2026	90.2×	90.26%
Jun 2026	47.4×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
5 more quarters	Free account

Against its own ten years

Low 0.0× High 106×

Ten-year median 0.0×

Current reading's percentile 89

Company	P/E ratio
TWST Twist Bioscience Corporation compare	n/m
ABVX Abivax SA Sponsored ADR compare	n/m
PRAX Praxis Precision Medicines, Inc. compare	n/m
CYTK Cytokinetics, Incorporated compare	n/m
ARWR Arrowhead Pharmaceuticals, Inc. compare	n/m
AXSM Axsome Therapeutics, Inc. compare	n/m
RYTM Rhythm Pharmaceuticals, Inc. compare	n/m
CORT Corcept Therapeutics Incorporated compare	47.8×
CAI Caris Life Sciences,�Inc.	73.9×
Biotechnology industry median	10.6×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Caris Life Sciences,�Inc. (CAI) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CAI

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CAI

Stockrow Weekly